Altoprev Overview
Manufactured and marketed by Andrx Pharmaceuticals, Altoprev belongs to a class of drugs known as HMG CoA reductase inhibitors (commonly known as statins) that work by reducing levels of ‘bad’ cholesterol (low-density lipoprotein, or LDL) and triglycerides in the blood, while increasing levels of ‘good’ cholesterol (high-density lipoprotein, or LDL). The medication is typically prescribed to lower the risk of stroke, heart attack and other heart complications in patients with diabetes, coronary heart disease, and other serious health conditions. Altoprev was approved by the U.S. Food & Drug Administration (FDA) in 2002.
